A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis

Abstract

This study supports the safety, tolerance, and efficacy of fluoxetine for hypochondriasis. Joint treatment provided a small incremental benefit. Because approximately 50% of patients did not respond to the study treatments, new or more intensive approaches are needed.